Launched in 2014, IBD Qorus is focused on improving health outcomes and how care is delivered to IBD patients across a range of U.S. locations, practice settings, and disease complexities. The program leverages a collaborative improvement network by bringing together healthcare teams and patients from IBD care centers across the country to systematically learn, share, and disseminate improvements in IBD care delivery.
The grant will support a three-year, two-phase expansion of the program. Phase one will be focused on optimizing the IBD Qorus experience for patients and providers at the thirty sites currently enrolled in the program. Phase two will work to increase patient and provider participation through the addition of new sites. The expansion also will support widespread dissemination of evidence-based standards and practices learned through the program that could lead to a better understanding of the disease and improved care for patients.
"We have seen great progress with IBD Qorus, including the development of anemia and nutrition care pathways, which are helping to promote the consistent application of standards of care for IBD patients," said Crohn's & Colitis Foundation president and CEO Michael Osso. "Through Helmsley's commitment to IBD patients and research, we are able to build additional resources that will help deliver on our mission to improve patient quality of life and, ultimately, drive toward cures."
(Photo credit: Getty Images)